403 related articles for article (PubMed ID: 18278078)
1. Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.
Stewart RA; North FM; Sharples KJ; Simes RJ; Tonkin AM; White HD;
N Z Med J; 2008 Feb; 121(1269):11-23. PubMed ID: 18278078
[TBL] [Abstract][Full Text] [Related]
2. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
3. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
Simes J; Furberg CD; Braunwald E; Davis BR; Ford I; Tonkin A; Shepherd J
Eur Heart J; 2002 Feb; 23(3):207-15. PubMed ID: 11792135
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey.
Metcalf PA; Scragg RR; Schaaf D; Dyall L; Black PN; Jackson RT
N Z Med J; 2008 Feb; 121(1269):45-56. PubMed ID: 18278081
[TBL] [Abstract][Full Text] [Related]
5. Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Tonelli M; Isles C; Curhan GC; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; Craven T; West M
Circulation; 2004 Sep; 110(12):1557-63. PubMed ID: 15364796
[TBL] [Abstract][Full Text] [Related]
6. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
7. Parametric conditional frailty models for recurrent cardiovascular events in the lipid study.
Cui J; Forbes A; Kirby A; Marschner I; Simes J; West M; Tonkin A
Clin Trials; 2008; 5(6):565-74. PubMed ID: 19029205
[TBL] [Abstract][Full Text] [Related]
8. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
Stewart RA; White HD; Kirby AC; Heritier SR; Simes RJ; Nestel PJ; West MJ; Colquhoun DM; Tonkin AM;
Circulation; 2005 Apr; 111(14):1756-62. PubMed ID: 15809366
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
[TBL] [Abstract][Full Text] [Related]
10. [Effects of socioeconomic status on the distribution of cardiovascular risk factors and clinical treatments of patients with acute myocardial infarction in Beijing].
Feng Q; Hu DY; Yang JG; Sun YH; Lu CL; Zhang SY; Song L; Zhang QT; Wu D; Zhang XQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):430-3. PubMed ID: 18956672
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond.
Ellis CJ; Hamer AW
N Z Med J; 2008 Feb; 121(1269):5-10. PubMed ID: 18278077
[No Abstract] [Full Text] [Related]
12. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Asselbergs FW; Diercks GF; Hillege HL; van Boven AJ; Janssen WM; Voors AA; de Zeeuw D; de Jong PE; van Veldhuisen DJ; van Gilst WH;
Circulation; 2004 Nov; 110(18):2809-16. PubMed ID: 15492322
[TBL] [Abstract][Full Text] [Related]
13. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular mortality in New Zealand and Australia 1968-1983: how can the diverging trends be explained?
Beaglehole R; Bonita R; Jackson R; Stewart A
N Z Med J; 1986 Jan; 99(794):1-3. PubMed ID: 3456096
[TBL] [Abstract][Full Text] [Related]
17. Relationship of different measures of socioeconomic status with cardiovascular disease risk factors and lifestyle in a New Zealand workforce survey.
Metcalf P; Scragg R; Davis P
N Z Med J; 2007 Jan; 120(1248):U2392. PubMed ID: 17277809
[TBL] [Abstract][Full Text] [Related]
18. Socioeconomic inequalities in cardiovascular disease mortality; an international study.
Mackenbach JP; Cavelaars AE; Kunst AE; Groenhof F
Eur Heart J; 2000 Jul; 21(14):1141-51. PubMed ID: 10924297
[TBL] [Abstract][Full Text] [Related]
19. Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery.
Papathanasiou A; Toumpoulis IK; Milionis HJ; Kalantzi K; Katsouras CS; Goudevenos J
Coron Artery Dis; 2008 Dec; 19(8):619-25. PubMed ID: 19005297
[TBL] [Abstract][Full Text] [Related]
20. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
